Mark Christopher National Eye Institute, Code F (Financial Support);
Christopher Bowd None;
Evan Walker None;
Akram Belghith None;
Michael Goldbaum None;
Jasmin Rezapour German Research Foundation, German Ophthalmological Society, Code F (Financial Support);
Massimo Fazio National Eye Institute, EyeSight Foundation of Alabama, Research to Prevent Blindness, Heidelberg Engineering, Code F (Financial Support);
Christopher Girkin National Eye Institute, EyeSight Foundation of Alabama, Research to Prevent Blindness, Heidelberg Engineering, Code F (Financial Support);
Gustavo De Moraes Novartis, Galimedix, Belite, Reichert, Carl Zeiss Meditec, Perfuse Therapeutics, Code C (Consultant/Contractor), Ora Clinical, Code E (Employment), Heidelberg Engineering, Topcon, Code R (Recipient);
Jeffrey Liebmann Alcon, Allergan, Bausch & Lomb, Carl Zeiss Meditec, Heidelberg Engineering, Reichert, Valeant Pharmaceuticals, Code C (Consultant/Contractor), Bausch & Lomb, Carl Zeiss Meditec, Heidelberg Engineering, National Eye Institute, Novartis, Optovue, Reichert Technologies, Research to Prevent Blindness, Code F (Financial Support);
Robert Weinreb Abbvie, Aerie Pharmaceuticals, Allergan, Equinox, Eyenovia, Nicox, Topcon, Code C (Consultant/Contractor), eidelberg Engineering, Carl Zeiss Meditec, Konan Medical, Optovue, Centervue, Bausch & Lomb, Topcon, National Eye Institute, Research to Prevent Blindness, Code F (Financial Support), Toromedes, Carl Zeiss Meditec, Topcon, Code P (Patent);
Andrzej Grzybowski Viatris, Polpharma, Thea, Code C (Consultant/Contractor);
Linda Zangwill Abbvie, Digital Diagnostics, Code C (Consultant/Contractor), National Eye Institute, Carl Zeiss Meditec Inc., Heidelberg Engineering GmbH, Optovue Inc., Topcon Medical Systems Inc., Code F (Financial Support), Carl Zeiss Meditec, Code P (Patent)